Reversal of drug-induced neuromuscular block using novel molecular containers
US9469648B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2011 |
| Grant date | Oct 18, 2016 |
| Priority date | — |
| Expiry date | Nov 22, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for reversing the effects of agents used for muscular immobilization and/or loss of consciousness and/or loss of pain perception. The method comprises administering a composition comprising acyclic CB[n]-type compounds to an individual in need of reversal of the effects of neuromuscular blocking agents and/or anesthetic agents such that the effects of the agent(s) are partially fully reversed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.